3-100609920-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032787.3(ADGRG7):c.64G>T(p.Gly22Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,613,848 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032787.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRG7 | NM_032787.3 | c.64G>T | p.Gly22Cys | missense_variant | 1/16 | ENST00000273352.8 | NP_116176.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRG7 | ENST00000273352.8 | c.64G>T | p.Gly22Cys | missense_variant | 1/16 | 1 | NM_032787.3 | ENSP00000273352 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000342 AC: 86AN: 251484Hom.: 0 AF XY: 0.000353 AC XY: 48AN XY: 135912
GnomAD4 exome AF: 0.000269 AC: 393AN: 1461646Hom.: 1 Cov.: 30 AF XY: 0.000297 AC XY: 216AN XY: 727142
GnomAD4 genome AF: 0.000283 AC: 43AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2021 | The c.64G>T (p.G22C) alteration is located in exon 1 (coding exon 1) of the ADGRG7 gene. This alteration results from a G to T substitution at nucleotide position 64, causing the glycine (G) at amino acid position 22 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at